TCRX: TScan Therapeutics, Inc. Stock

by  •  • Comments Off on TCRX: TScan Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 383.26
Enterprise Value ($M) 272.99
Book Value ($M) 122.97
Book Value / Share 2.33
Price / Book 3.12
NCAV ($M) 46.86
NCAV / Share 0.89
Price / NCAV 8.18

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 5.23
Current Ratio 5.23

Balance Sheet (mrq) ($M)
Current Assets 164.72
Assets 240.83
Liabilities 117.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 21.05
Operating Income -93.46
Net Income -89.22

Cash Flow Statement (mra) ($M)
Cash From Operations -61.36
Cash from Investing -60.76
Cash from Financing 135.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-29 13G Cormorant Asset Management, LP 5.15
04-23 13D/A Baker Bros. Advisors Lp 6.10 1.25
02-14 13G/A K2 HealthVentures Equity Trust LLC 9.98 118.50
02-14 13G/A Lynx1 Capital Management LP 7.80 -4.14
02-09 13G/A Gv 2017, L.p. 2.50 0.00
02-08 13G/A Pitango HealthTech Fund I, L.P. 4.30 92.59
02-07 13G/A Adage Capital Partners Gp, L.l.c. 8.96 -2.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-10 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ T
2024-03-06 10-K Form 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 27,889 175,460 15.89
2024-07-25 28,376 194,579 14.58
2024-07-24 44,481 149,479 29.76
2024-07-23 31,509 154,821 20.35
2024-07-22 45,207 142,999 31.61

(click for more detail)

Similar Companies
SUPN – Supernus Pharmaceuticals, Inc. TARA – Protara Therapeutics, Inc.
TBPH – Theravance Biopharma, Inc. TENK – TenX Keane Acquisition
TKNO – Alpha Teknova, Inc.


Financial data and stock pages provided by
Fintel.io